The revenue stands at ₹7,474.66 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.29 per cent from ₹7,167.52 crore. This corresponds to a year-on-year *(YoY) growth of 31.89 per cent.
Operating Profit stands at ₹2,354.24 crore, reflecting a quarter-on-quarter *(QoQ) increase of 28.28 per cent from ₹1,835.28 crore. This corresponds to a year-on-year *(YoY) growth of 78.19 per cent.
PBDT stands at ₹2,374.79 crore, reflecting a quarter-on-quarter *(QoQ) increase of 29.42 per cent from ₹1,835.00 crore. This corresponds to a year-on-year *(YoY) growth of 84.23 per cent.
Profit Before Tax stands at ₹1,928.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 26.67 per cent from ₹1,522.04 crore. This corresponds to a year-on-year *(YoY) growth of 115.22 per cent.
Net Profit stands at ₹1,468.67 crore, reflecting a quarter-on-quarter *(QoQ) increase of 24.41 per cent from ₹1,180.51 crore. This represents a 87.72 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Lupin | -0.99% | -0.47% | 5.98% | 5.19% | 15.30% | 22.53% |
| Cipla | -0.72% | 0.28% | 6.00% | 21.35% | -4.07% | -3.38% |
| Dr Reddy's Labs | -1.43% | -2.83% | 5.92% | 9.88% | 7.10% | 3.41% |
| Zydus Lifesci. | -0.30% | -1.14% | 3.01% | 27.99% | 20.29% | 10.95% |
| Mankind Pharma | -2.35% | 0.20% | 5.01% | 23.34% | 13.53% | 5.36% |
| Aurobindo Pharma | -1.32% | 0.40% | 7.96% | 16.06% | 28.79% | 34.57% |
| Laurus Labs | -1.48% | -0.36% | 7.38% | 41.48% | 35.80% | 97.53% |
Chairman (Non-Executive) : M D Gupta
Managing Director : Nilesh Deshbandhu Gupta.
Director & Chief Executive Officer : Vinita Gupta
Company Sec. & Compli. Officer : R V Satam
Independent Director : Jean-Luc Belingard
Director & Group CFO : Ramesh Swaminathan
Independent Director : Mark D McDade
Independent Director : K B S Anand
Independent Director : Jeffrey Kindler
Independent Director : Alfonso Zulueta
Independent Director : Punita Lal